Holsamed

Katowice 40-851

1 studies enrolling now · 2 studies all time

What they study most

Atopic Dermatitis, Hidradenitis Suppurativa (HS)

Studies at this site

• A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa — Recruiting now
• Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin) — Completed